Part of the Adrem Data Lab
Department of Computer Science
University of Antwerp (Belgium)
Kris Laukens is a professor in bioinformatics and biodata mining at the Biomedical informatics research network (biomina) and the Adrem data Lab at the University of Antwerp. His multidisciplinary biodata mining research team has the ambition to remove crucial limitations in the interpretation of big molecular and clinical data by introducing cutting-edge data mining and machine learning technology that transforms complex biomedical data in actionable insights. The developed techniques are used to make novel discoveries in diverse life science areas, ranging from systems biology to personalized medicine.
The lab has published over 130 peer reviewed journal publications. You can check the official institutional bibliography or Google Scholar profile of Kris Laukens.
The lab is partner in over 15 million euros in research grants, received from various national and international funding agencies and industry. For a list, check this official overview of funded projects.
The lab holds a long list of academic and non-academic collaborators, including hospitals (UZA), research institutes (ITM, Vito, VIB, SCK) and diverse pharmaceutical and biotechnology companies.
The lab is actively seeking opportunities to transform its technology into societal and economical impactful solutions, through licensing its intellectual property portfolio to third parties. Research at the Laukens lab has led to two spin-off companies, and several proof-of-concept and venture incorporation trajectories are in the pipeline.
ImmuneWatch BV is a bioinformatics spin-off company created to accelerate the development of T-cell based diagnostic tools and therapies using bioinformatics and AI. The mission is to make immune repertoire data interpretable and actionable by annotating T-cell receptors in a clinically meaningful way. It was co-founded in 2021 by team members Kris Laukens and Pieter Meysman based on patented in house developed technology.
Innocens BV is a digital health spin-off company based on a collaboration between the Neonatal Intensive Care Unit of the University Hospital of Antwerp (UZA), the Adrem Data Lab and industry partner (IBM). Innocens is an acronym that stands for Improving Neonatal Outcome with a Clinical Early Notification System. It is a Clinical Decision Support System based on Artificial Intelligence technology, currently including a predictive model for Late onset Sepsis.
The lab is responsible for a number of courses, mainly at the University of Antwerp, at the interface of life sciences and data sciences. We offer compulsive and elective courses in diverse life science and computational science curricula. Besides these fixed courses, the team is frequently asked to offer specialised and customised trainings to researchers and clinicians in public and industry sectors.
We always offer opportunities for bachelor, master, PhD and postdoctoral level internships in the field of bioinformatics, biomedical AI or digital health, for students with life science or computer science backgrounds. Get in touch with us if you want to explore if this could be something for you.